Henry M. Blumberg

Henry M. Blumberg

Auto-generated profile, based on publicly available information

Henry M. Blumberg

Division of Infectious Disease, Department of Medicine, Emory University School of Medicine, Atlanta, GA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2001 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
HBHenry M. Blumberg
Henry M. Blumberg
WJWilliam R. Jarvis
William R. Jarvis
JSJ. Michael Soucie
J. Michael Soucie
JEJack E. Edwards
Jack E. Edwards
JPJan E. Patterson
Jan E. Patterson
TGthe NEMIS Study Group
the NEMIS Study Group
To assess risk factors for development of candidal blood stream infections (CBSIs), a prospective cohort study was performed at 6 sites that involved

23 April 2009 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
LJLeo Jeng
Leo Jeng
AYAlexandra V Yamshchikov
Alexandra V Yamshchikov
SJSuzanne E Judd
Suzanne E Judd
HBHenry M Blumberg
Henry M Blumberg
GMGreg Martin
Greg Martin
Vin TangprichaVin Tangpricha
Vin Tangpricha
Background: Vitamin D insufficiency is common in hospitalized patients. Recent evidence suggests that vitamin D may enhance the innate immune response by induction of cathelicidin (LL-37), an endogenous antimicrobial peptide produced by macrophages and neutrophils. Thus, the relationship between vitamin D status and LL-37 production may be of importance for host immunity, but little data is available on this subject, especially in the setting of human sepsis syndrome and other critical illness. Methods: Plasma concentrations of 25-hydroxyvitamin D (25(OH)D), vitamin D binding protein (DBP) and LL-37 in critically ill adult subjects admitted to intensive care units (ICUs) with sepsis and without sepsis were compared to healthy controls. Results: Critically ill subjects had significantly lower plasma 25(OH)D concentrations compared to healthy controls. Mean plasma LL-37 levels were significantly lower in critically ill subjects compared to healthy controls. Vitamin D binding protein levels in plasma were significantly lower in critically ill subjects with sepsis compared to critically ill subjects without sepsis. There was a significant positive association between circulating 25(OH)D and LL-37 levels. Conclusion: This study demonstrates an association between critical illness and lower 25(OH)D and DBP levels in critically ill patients as compared to healthy controls. It also establishes a positive association between vitamin D status and plasma LL-37, which suggests that systemic LL-37 levels may be regulated by vitamin D status. Optimal vitamin D status may be important for innate immunity especially in the setting of sepsis. Further invention studies to examine this association are warranted.

21 May 2020 in JCI Insight
Verified
Journal Article
Open access
PDF file
JCJeffrey M. Collins
Jeffrey M. Collins
ASAmnah Siddiqa
Amnah Siddiqa
DJDean P. Jones
Dean P. Jones
KLKen Liu
Ken Liu
RKRussell R. Kempker
Russell R. Kempker
TZThomas Ziegler
Thomas Ziegler
There is limited understanding of the role of host metabolism in the pathophysiology of human tuberculosis (TB). Using high-resolution metabolomics with an unbiased approach to metabolic pathway analysis, we discovered that the tryptophan pathway is highly regulated throughout the spectrum of TB infection and disease. This regulation is characterized by increased catabolism of tryptophan to kynurenine, which was evident not only in active TB disease but also in latent TB infection (LTBI). Further, we found that tryptophan catabolism is reversed with effective treatment of both active TB disease and LTBI in a manner commensurate with bacterial clearance. Persons with active TB and LTBI also exhibited increased expression of indoleamine 2,3-dioxygenase-1 ( IDO-1 ), suggesting IDO-1 mediates observed increases in tryptophan catabolism. Together, these data indicate IDO-1–mediated tryptophan catabolism is highly preserved in the human response to Mycobacterium tuberculosis and could be a target for biomarker development as well as host-directed therapies.

10 February 2009 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
NTNaasha J Talati
Naasha J Talati
USUlrich Seybold
Ulrich Seybold
BHBianca Humphrey
Bianca Humphrey
AAAbiola Aina
Abiola Aina
JTJane Tapia
Jane Tapia
HBHenry M Blumberg
Henry M Blumberg
A new generation of diagnostic tests, the interferon-γ release assays (IGRAs), have been developed for the detection of latent tuberculosis infection (LTBI). Limited data are available on their use in HIV-infected persons.

24 September 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JCJeffrey M. Collins
Jeffrey M. Collins
DJDean P. Jones
Dean P. Jones
ASAshish Sharma
Ashish Sharma
MKManoj Khadka
Manoj Khadka
KLKen H. Liu
Ken H. Liu
TZThomas R. Ziegler
Thomas R. Ziegler
The metabolic signaling pathways that drive pathologic tissue inflammation and damage in humans with pulmonary tuberculosis (TB) are not well understood. Using combined methods in plasma high-resolution metabolomics, lipidomics and cytokine profiling from a multicohort study of humans with pulmonary TB disease, we discovered that IL-1β-mediated inflammatory signaling was closely associated with TCA cycle remodeling, characterized by accumulation of the proinflammatory metabolite succinate and decreased concentrations of the anti-inflammatory metabolite itaconate. This inflammatory metabolic response was particularly active in persons with multidrug-resistant (MDR)-TB that received at least 2 months of ineffective treatment and was only reversed after 1 year of appropriate anti-TB chemotherapy. Both succinate and IL-1β were significantly associated with proinflammatory lipid signaling, including increases in the products of phospholipase A2, increased arachidonic acid formation, and metabolism of arachidonic acid to proinflammatory eicosanoids. Together, these results indicate that decreased itaconate and accumulation of succinate and other TCA cycle intermediates is associated with IL-1β-mediated proinflammatory eicosanoid signaling in pulmonary TB disease. These findings support host metabolic remodeling as a key driver of pathologic inflammation in human TB disease. Pulmonary tuberculosis (TB) often results in pathologic lung inflammation that causes tissue damage and does not control bacterial replication. This impairs the host response to antibiotic treatment and can result in long term deficits in lung function. Currently, the role of host metabolism in regulating the inflammatory response in TB disease is not well understood. Here, we use detailed immunometabolic phenotyping to show that metabolic remodeling of the tricarboxylic acid (TCA) cycle is closely associated with pathologic inflammatory signaling in humans with TB disease. Accumulation of TCA cycle intermediates in plasma, including the proinflammatory metabolite succinate, as well as decreased concentrations of the anti-inflammatory metabolite itaconate, were associated with increases in IL-1β and upregulation of proinflammatory lipid signaling cascades. This inflammatory network was upregulated following delays in appropriate anti-TB treatment and was associated with prolonged time to sputum culture clearance of Mycobacterium tuberculosis. Our study provides new insights into the metabolic reprograming that leads to pathologic inflammation in humans with pulmonary TB.

1 March 2002 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
PDF file
NRNilton A. Rezende
Nilton A. Rezende
HBHenry M. Blumberg
Henry M. Blumberg
SRSusan M. Ray
Susan M. Ray
BMBrian S. Metzger
Brian S. Metzger
NLNina M. Larsen
Nina M. Larsen
JMJohn E. McGowan
John E. McGowan